pCMV-Flag-YAP-S94A Citations (7)
Originally described in: TEAD mediates YAP-dependent gene induction and growth control.Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL Genes Dev. 2008 Jul 15. 22(14):1962-71. PubMed Journal
Articles Citing pCMV-Flag-YAP-S94A
| Articles |
|---|
| Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Cox AG, Hwang KL, Brown KK, Evason KJ, Beltz S, Tsomides A, O'Connor K, Galli GG, Yimlamai D, Chhangawala S, Yuan M, Lien EC, Wucherpfennig J, Nissim S, Minami A, Cohen DE, Camargo FD, Asara JM, Houvras Y, Stainier DY, Goessling W. Nat Cell Biol. 2016 Aug;18(8):886-96. doi: 10.1038/ncb3389. Epub 2016 Jul 18. PubMed |
| YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth. Jiang N, Ke B, Hjort-Jensen K, Iglesias-Gato D, Wang Z, Chang P, Zhao Y, Niu X, Wu T, Peng B, Jiang M, Li X, Shang Z, Wang Q, Chang C, Flores-Morales A, Niu Y. Oncotarget. 2017 Dec 7;8(70):115054-115067. doi: 10.18632/oncotarget.23014. eCollection 2017 Dec 29. PubMed |
| Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion. Wu A, Wu Q, Deng Y, Liu Y, Lu J, Liu L, Li X, Liao C, Zhao B, Song H. EMBO J. 2019 Jan 3;38(1). pii: embj.201899506. doi: 10.15252/embj.201899506. Epub 2018 Nov 5. PubMed |
| The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth. Morice S, Mullard M, Brion R, Dupuy M, Renault S, Tesfaye R, Brounais-Le Royer B, Ory B, Redini F, Verrecchia F. Cancers (Basel). 2020 Dec 20;12(12). pii: cancers12123847. doi: 10.3390/cancers12123847. PubMed |
| PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Muller cells during diabetic retinopathy. Guo Y, Cang X, Zhu L, Zhu M, Li A, Wang Z, Zhang Y, Wang X, Song E. Exp Eye Res. 2021 Sep;210:108703. doi: 10.1016/j.exer.2021.108703. Epub 2021 Jul 17. PubMed |
| Involvement of the TGF-beta Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis. Morice S, Danieau G, Tesfaye R, Mullard M, Brion R, Dupuy M, Ory B, Brounais-Le Royer B, Corre I, Redini F, Verrecchia F. Front Oncol. 2021 Oct 26;11:765711. doi: 10.3389/fonc.2021.765711. eCollection 2021. PubMed |
| BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway. Jiang N, Liao Y, Wang M, Wang Y, Wang K, Guo J, Wu P, Zhong B, Guo T, Wu C. J Exp Clin Cancer Res. 2021 Dec 1;40(1):378. doi: 10.1186/s13046-021-02179-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.